Atorvastatin/ezetimibe - Merck & Co
At a glance
- Drug Originator Merck/Schering-Plough Pharmaceuticals
- Drug Licenced by Rovi
- Drug Class Amides; Antihyperlipidaemics; Azetidines; Fatty acids; Fluorobenzenes; Heptanoic acids; Propanols; Pyrroles
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors; NPC1L1 protein inhibitors
- USA Patent Applicants ORGANON
- USA Patents 4
- NDAs 1
Table of Contents

Disclaimer